| |
| |
|
| Insider
Information: |
Mainolfi Nello |
| Relationship: |
|
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
615,570 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
615,570 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kymera Therapeutics, Inc. |
KYMR |
|
2024-01-02 |
615,570 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2023-11-03 |
4 |
OE |
$2.08 |
$41,600 |
D/D |
20,000 |
606,570 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-01-10 |
4 |
AS |
$52.46 |
$1,196,397 |
D/D |
(22,465) |
472,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-01-10 |
4 |
OE |
$2.08 |
$46,727 |
D/D |
22,465 |
494,664 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-09 |
4 |
OE |
$2.08 |
$47,412 |
D/D |
22,794 |
398,993 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-09 |
4 |
AS |
$33.58 |
$767,750 |
D/D |
(22,794) |
376,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-06-10 |
4 |
AS |
$50.63 |
$1,182,106 |
D/D |
(23,009) |
412,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-06-10 |
4 |
OE |
$2.08 |
$47,859 |
D/D |
23,009 |
435,208 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-08-02 |
4 |
OE |
$2.08 |
$48,788 |
D/D |
23,456 |
475,655 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-08-02 |
4 |
AS |
$60.21 |
$1,414,404 |
D/D |
(23,456) |
452,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-06-14 |
4 |
OE |
$2.08 |
$83,200 |
D/D |
40,000 |
452,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-10-08 |
4 |
AS |
$55.56 |
$2,357,946 |
D/D |
(41,544) |
464,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-10-08 |
4 |
OE |
$2.08 |
$86,412 |
D/D |
41,544 |
505,743 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-07-08 |
4 |
OE |
$2.08 |
$99,840 |
D/D |
48,000 |
500,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-07-08 |
4 |
AS |
$49.15 |
$2,385,628 |
D/D |
(48,000) |
452,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-10-17 |
4 |
OE |
$2.08 |
$124,243 |
D/D |
59,732 |
561,931 |
0 |
- |
|
65 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
